<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A patient with a history of early <z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> and repeated fetal <z:hpo ids='HP_0011420'>death</z:hpo>, high titer IgG anticardiolopin antibodies and prolonged aPTT was treated during her third pregnancy with intravenous immunoglobulins (IVIG) from the seventh month of pregnancy onwards </plain></SENT>
<SENT sid="1" pm="."><plain>Every month--after a loading dose of 30 g immunoglobulins--a daily infusion of 3 g immunoglobulin was for three days was given during six consecutive cycles </plain></SENT>
<SENT sid="2" pm="."><plain>The patients pregnancy ended preterm with a life birth, delivered by cesarean section, because of a <z:e sem="disease" ids="C0341950,C0156669" disease_type="Disease or Syndrome" abbrv="">severe preeclampsia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The 1600 g weighing boy was in good health </plain></SENT>
<SENT sid="4" pm="."><plain>Each treatment with IVIG resulted in a reduction of anticardiolipin-antibodies </plain></SENT>
<SENT sid="5" pm="."><plain>During the seventh months observation period, a gradual increase in PAI activity/factor VIIIR:Ag was found </plain></SENT>
<SENT sid="6" pm="."><plain>A partial transient reduction of <z:hpo ids='HP_0003613'>antiphospholipid-antibody</z:hpo> levels was observed immediately following each treatment course resulting in an accelerated fetal outcome </plain></SENT>
</text></document>